INSTITUTE OF MICROBIAL TECHNOLOGY
Institutes
Contact Details:
Send Enquiry Form
Address: 39A, Sector 39, Chandigarh, 160036, India
Phone Number: +91-172-6665202
Email ID: n/a (Edit business Listing)
Website: imtech.res.in
Products Services: Institute of Microbial Technology Dr. Anil Koul, prior to taking the charge of Director, CSIR-IMTech, was Senior Director & Head, Respiratory Infections Discovery group at global healthcare giant Johnson & Johnson. He has more than 16 years of experience in pharmaceutical drug discovery research and clinical development. He obtained his Ph.D. from Max-Planck Institute for Biochemistry in Munich, Germany and Delhi University, Delhi. As a part of continued education, in 2011, he attended a short residential program at Harvard Business School, USA on innovation, strategy and leadership.
Dr. Anil Koul has been a key scientist in discovery and clinical development of SIRTUROTM (generically called Bedaquiline)- the first tuberculosis drug to be granted approved by United State FDA and EU in last 40 years. In 2013, he was awarded “Johnson Medal”, the highest R&D prize by Johnson and Johnson for contributions to discovery and development of SIRTUROTM.Recently, he was invited to European Parliament to present to members of Europe-India Chamber of Commerce *EICC) on SIRTURO and global public health. Earlier, he was also awarded ‘The Philip B. Hofmann Prize ‘ for his discovery of SIRTUROs mode of action and he has also been conferred with “Swiss-TB prize” by Switzerland’s Society of Pneumologyfor outstanding scientific research in the year 2005.
Dr. Koul is a well-known and respected expert in Infectious diseases with >35 peer reviewed publications in leading journals like Nature and Science, > 40 presentations at International congress and more than 30 patents to this credit. He and his research team at Janssen have also discovered several new drugs (currently in clinical development) for diseases ranging from viral bronchiolitis/infections, novel antibiotics to animal health. Prior to Janssen,he worked in Germany in a biotech company on the development of kinase inhibitors for oncology and other diseases.
Dr. Koul is a visiting professor at Faculty of Sciences at Free University of Amsterdam, Netherlands. He has featured in Voice of America’s scientific radio news analysis on challenges in drug development for neglected diseases.
Facebook:
Not Found? Create Facebook Page
Maps & Location:
Send Enquiry Form
Owner of this business listing? Claim this page or update using this link or Contact Us.